2-Chloro-4-({(1R,2S)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-2-hydroxypropyl}amino)-3-methylbenzonitrile(CAS: 1182367-47-0)

This compound should adhere to GHS classification, which includes health, environmental, and physical hazard assessments. For EU markets, REACH regulations require registration, evaluation, authorization, and restriction of chemicals. FDA and EPA have specific guidelines for handling and disposal, including testing for residual contaminants and proper waste management procedures.

Alternative reagents such as 2-chloro-4-(1-phenylethylamino)-3-methylbenzonitrile or other oxadiazole derivatives can be used. Isomers and analogs also offer potential alternatives depending on the desired chemical properties.

The compound is currently under research for its potential applications in pharmaceuticals and materials science. Market trends indicate increasing interest in its synthesis and utilization, although specific applications are still being explored.

Waste should be collected in appropriate containers and stored safely until disposal. Incineration or professional waste disposal services are recommended, ensuring compliance with local environmental protection regulations to minimize environmental impact.